Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jason Ryan Insider Profile
4 Followers
Jason Ryan, CFO at Foundation Medicine, holds 0.00 shares in Foundation Medicine (Ticker: FMI), holds ― shares in Dianthus Therapeutics (Ticker: DNTH), holds 145.76K shares in GeneDx Holdings (Ticker: WGS).
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+170.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jason Ryan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jason Ryan
Jason Ryan's Trading History
Foundation Medicine
Aug 02, 2018
―
Uninformative Sell
6.74M
$0.00
Dianthus Therapeutics
―
Chief Operating and Financial Officer
―
―
GeneDx Holdings
Nov 21, 2024
Director
Uninformative Sell
―
$10.13M
Singular Genomics Systems
―
Director
―
―
SomaLogic
―
―
―
―
List of latest transactions for each holding click on a transaction to see Jason Ryan's performance on stock
You May Also Like
Jason Ryan insider profile FAQ
What is the percentage of profitable transactions made by Jason Ryan?
The percentage of profitable transactions made by Jason Ryan is 60%.
What is the average return per transaction made by Jason Ryan?
The average return per transaction made by Jason Ryan is 170.40%.
What stocks does Jason Ryan hold?
Jason Ryan holds: FMI, DNTH, WGS, OMIC, SLGC stocks.
What was Jason Ryan’s latest transaction?
Jason Ryan latest transaction was an Uninformative Sell of $6.74M.
What was Jason Ryan's most profitable transaction?
Jason Ryan’s most profitable transaction was an Informative Buy of WGS stock on November 20, 2023. The return on the trade was 800.00%.
What is Jason Ryan's role in Foundation Medicine?
Jason Ryan's role in Foundation Medicine is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.